#1 Clinical Trials Search in Europe

Capsaicin

Capsaicin, the active compound found in chili peppers, is being extensively studied in clinical trials for its potential to manage various types of pain. This article explores how capsaicin is being used in different formulations and applications to treat conditions ranging from neuropathic pain to chest pain perception. We’ll examine the latest research on capsaicin’s effectiveness, safety, and potential benefits for patients suffering from chronic pain conditions.

Table of Contents

What is Capsaicin?

Capsaicin is a natural compound found in chili peppers that is known for its pain-relieving properties. It is the active ingredient in various medical treatments, particularly for managing different types of pain. Capsaicin works by desensitizing pain receptors in the skin, which can lead to a reduction in pain sensations[1]. This compound is also known by its chemical name, 8-Methyl-N-vanillyl-trans-6-nonenamide[2].

Conditions Treated with Capsaicin

Capsaicin is used to treat various conditions, including:

  • Neuropathic pain: This is pain caused by damage or dysfunction of the nervous system. Capsaicin has shown effectiveness in treating neuropathic pain associated with conditions such as:
    • Diabetic neuropathy (nerve pain related to diabetes)[3]
    • Post-herpetic neuralgia (pain following shingles)[4]
    • HIV-associated neuropathy[4]
  • Coccygodynia: This is pain in the tailbone area. Capsaicin is being studied for its potential to relieve this type of pain[5].
  • Critical ischemia in end-stage renal failure: This is a condition where there is severe pain due to poor blood flow in patients with kidney failure. Capsaicin is being investigated as a treatment option for this difficult-to-manage pain[4].
  • Pain associated with lower limb amputation: Capsaicin is being studied for its potential to prevent neuropathic pain following limb amputation[1].

Forms and Applications of Capsaicin

Capsaicin is available in various forms for medical use:

  • Topical patches: One of the most common forms is the Qutenza patch, which contains 8% capsaicin. This patch is applied to the skin for a specific duration, typically 30-60 minutes, depending on the condition being treated[6].
  • Creams and gels: Capsaicin is also available in lower concentrations (e.g., 0.075%) as creams or gels that can be applied directly to the skin[3].
  • Topical solutions: Some formulations come as topical solutions that can be applied using a roll-on applicator[3].

Effectiveness of Capsaicin

Studies have shown that capsaicin can be effective in reducing pain for various conditions:

  • In neuropathic pain conditions, capsaicin patches have demonstrated significant pain reduction lasting up to 12 weeks after a single application[4].
  • For diabetic neuropathy, one study found a 31.5% reduction in mean pain scores during weeks 2-12 post-treatment[4].
  • In studies of post-herpetic neuralgia and HIV neuropathy, pain reduction ranged from 30-32% compared to 20-24% with a lower concentration control[4].

Side Effects and Tolerability

While capsaicin is generally well-tolerated, it can cause some side effects, particularly at the application site:

  • Common side effects include temporary burning, redness, or itching at the application site[4].
  • More severe side effects like blistering are rare, occurring in less than 5% of cases[4].
  • Patients with diabetes should be monitored closely, as there is a slight risk of skin ulceration[4].

Ongoing Research and Potential Uses

Researchers are exploring new potential uses for capsaicin:

  • Chest pain perception: Studies are investigating whether capsaicin sensitivity could be used to assess an individual’s ability to perceive chest pain related to heart problems[7].
  • Cerebral blood flow: Research is being conducted to determine if capsaicin can increase blood flow to the brain, which could have implications for treating certain neurological conditions[2].
  • Pain management in pulmonary arterial hypertension: Capsaicin is being studied as a potential treatment for pain associated with subcutaneous infusion of treprostinil, a medication used for pulmonary arterial hypertension[8].
Aspect Details
Primary Uses Neuropathic pain, coccygodynia, chest pain, critical ischemia pain, arteriovenous fistula pain
Administration Methods Topical patches (e.g., Qutenza 8% capsaicin), creams, transdermal applications
Duration of Effect Up to 12 weeks after a single application in some studies
Common Side Effects Temporary burning, stinging, or redness at application site
Unique Benefits Minimal systemic absorption, potentially fewer side effects than oral medications
Patient Populations End-stage renal failure, diabetics, post-surgical patients, chronic pain sufferers
Ongoing Research Pre-emptive analgesia, cerebral blood flow effects, pain perception in cardiac patients

FAQ

  • What is capsaicin and how does it work for pain relief? Capsaicin is the active compound found in chili peppers. It works by desensitizing pain receptors in the skin, leading to a reduction in pain signals. When applied topically in high concentrations, it can provide long-lasting pain relief for certain conditions.
  • What types of pain conditions are being studied with capsaicin treatments? Clinical trials are exploring capsaicin for various pain conditions, including neuropathic pain, coccygodynia (tailbone pain), chest pain, pain from critical ischemia in end-stage renal failure, and pain associated with arteriovenous fistulae used for dialysis.
  • How is capsaicin typically administered in these clinical trials? Capsaicin is often administered as a topical treatment. Many trials use Qutenza, which is an 8% capsaicin patch applied to the skin for a specific duration. Other forms include creams and transdermal patches with varying concentrations of capsaicin.
  • Are there any side effects associated with capsaicin treatments? Common side effects include temporary burning, stinging, or redness at the application site. These effects are usually mild to moderate and diminish over time. Serious side effects are rare, but skin should be monitored for any signs of irritation or blistering.
  • How long does the pain relief from capsaicin treatments typically last? The duration of pain relief can vary depending on the condition and the specific capsaicin formulation used. Some studies report pain relief lasting up to 12 weeks after a single application of high-concentration capsaicin patches like Qutenza.

Ongoing Clinical Trials on Capsaicin

  • Study Comparing Serratus Plane Block, Capsaicin, and Botulinum Toxin Type A for Chronic Pain in Post-Mastectomy Patients

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Capsaicin for Finger Pain in Digital Osteoarthritis Patients

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Capsaicin Patch for Treating Chronic Neuropathic Pain in Children Aged 12-17

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study Comparing Capsaicin Patch and Duloxetine for Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • A study testing capsaicin patches compared to placebo for patients with painful diabetic nerve damage to assess effects on nerve symptoms and nerve fibers

    Not yet recruiting

    1 1
    Investigated drugs:
    Germany

  • Study on Rimegepant and Capsaicin for Migraine in Lean and Obese Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Capsaicin Patch and Amitriptyline for Neuropathic Pain in Head and Neck Cancer Patients in Remission

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France The Netherlands Poland Spain

  • Study on Botulinum Toxin Type A and Capsaicin for Treating Postmastectomy Pain in Women After Breast Cancer Surgery

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

Glossary

  • Capsaicin: The active compound found in chili peppers that has pain-relieving properties when applied topically in high concentrations.
  • Neuropathic pain: Pain caused by damage or dysfunction of the nervous system, often described as burning, tingling, or shooting pain.
  • Qutenza: A brand name for an 8% capsaicin patch used in clinical trials for various pain conditions.
  • Coccygodynia: Pain in the tailbone area, often aggravated by sitting or standing up from a seated position.
  • Arteriovenous fistula: An artificial connection between an artery and a vein, typically created for dialysis access in patients with end-stage renal failure.
  • TRPV1: Transient Receptor Potential Vanilloid 1, a pain receptor in the skin that is targeted by capsaicin.
  • Critical ischemia: A severe blockage in the arteries of the lower extremities or hands, resulting in pain at rest due to insufficient blood flow.
  • Transcranial Doppler (TCD): A non-invasive ultrasound technique used to measure blood flow velocity in the brain's blood vessels.
  • Visual Analog Scale (VAS): A measurement tool used to help patients rate the intensity of their pain on a scale, typically from 0 to 10.
  • Pulsatility Index (PI): A measure of blood flow resistance in blood vessels, calculated using Doppler ultrasound measurements.

References

  1. https://clinicaltrials.gov/study/NCT01748435
  2. https://clinicaltrials.gov/study/NCT05543837
  3. https://clinicaltrials.gov/study/NCT05029297
  4. https://clinicaltrials.gov/study/NCT01704339
  5. https://clinicaltrials.gov/study/NCT05983263
  6. https://clinicaltrials.gov/study/NCT03317613
  7. https://clinicaltrials.gov/study/NCT02346903
  8. https://clinicaltrials.gov/study/NCT01260454